Validation of a Novel Real-Time PCR for Detecting Rasamsonia Argillacea

Validation of a Novel Real-Time PCR for Detecting Rasamsonia Argillacea

NEW MICROBES IN HUMANS – NEW RESISTANT MICROBES IN HUMANS 10.1002/nmi2.44 Validation of a novel real-time The real-time PCR assay is a sensitive and specific method for PCR for detecting Rasamsonia detecting the three most important species of the R. argillacea species complex encountered in the CF context. Detection of argillacea species complex in these emerging pathogens in respiratory secretions from CF respiratory secretions from cystic patients by this novel assay may increase our understanding of the occurrence and epidemiology of the R. argillacea species fibrosis patients complex. Keywords: Cystic fibrosis, Geosmithia, PCR, Rasamsonia Original Submission: 25 November 2013; Revised J. Steinmann1, S. Giraud2, D. Schmidt1, L. Sedlacek3, Submission: 14 February 2014; Accepted: 21 March 2014 A. Hamprecht4, J. Houbraken5, J. F. Meis6,7, J. P. Bouchara2,8, Article published online: 20 April 2014 J. Buer1 and P.-M. Rath1 New Microbe and New Infect 2014; 2: 72–78 1) Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany, 2) L’UNAM Universite, Universite 0 0 d Angers, Groupe d Etude des Interactions H^ote-Pathogene, Angers, France, Corresponding author: J. Steinmann, Institute of Medical 3) Institute of Medical Microbiology and Hospital Epidemiology, Hannover Microbiology, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany Medical School, Hannover, 4) Institute for Medical Microbiology, Immunology E-mail: [email protected] and Hygiene, University Hospital of Cologne, Cologne, Germany, Presented in part: 47th 33 Annual Meeting of the Ger- 5) CBS-KNAW Fungal Biodiversity Centre, Utrecht, 6) Department of man-Speaking Mycological Society 34 (DMykG), Tubingen, Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Germany, 5–7 September 2013. Poster P19. Hospital, 7) Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands and 8) Laboratory of Parasitology and Mycology, Angers University Hospital, Angers, France Introduction Abstract Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene. This disease occurs in ~ 1 in 2500 live births in Members of the recently introduced fungal genus Rasamsonia the Caucasian population [1] and affects exocrine glands of (formerly included in the Geosmithia genus) have been described as several organs, particularly the lungs, where it results in the emerging pathogens in immunosuppressed hosts or patients with production of thick and sticky mucus. In the lower airways, this cystic fibrosis (CF). Rasamsonia species have often been misiden- provides an ideal breeding ground for many microorganisms tified as Penicillium or Paecilomyces because of similar morpholog- and facilitates recurrent respiratory infections with viruses, ical characteristics. We validated a commercially available bacteria and fungi [2]. Aspergillus fumigatus is the most real-time PCR assay (PrimerdesignTM, UK) for accurate detection prevalent filamentous fungus in the respiratory tract of CF of species from the Rasamsonia argillacea complex. First, we tested patients [3]. It has been reported that CF patients chronically this assay with a collection of 74 reference strains and clinical colonized with A. fumigatus have a decreased lung function, isolates and then compared the PCR with cultures of 234 more frequent exacerbations and more prominent radiological respiratory samples from 152 patients with CF from two abnormalities than non-colonized or transiently colonized CF University Hospitals in Germany and France. The assay reliably patients [4]. Besides Aspergillus spp., Scedosporium/Pseudalle- detected the three main species within the Rasamsonia argillacea scheria species were reported ranking usually second among species complex (R. argillacea, R. piperina, R. aegroticola), which are the filamentous fungi colonizing the CF airways [5–7]. Also typically encountered in CF patients. The limit of DNA detection other moulds like Aspergillus terreus or Exophiala dermatitidis was between 0.01 and 1 pg/lL. Analysis of the DNA extracts may also be encountered in the CF context, with prevalence from respiratory specimens of CF patients revealed that four out rates varying from one country to another. However, the of the 153 patients studied (2.6%) were colonized with R. arg- clinical relevance of the airway colonization by non-A. fumig- illacea species complex. Two species from the R. argillacea atus moulds is not clearly established. Recently, a new species complex grew in the parallel cultures from the same patients. complex, R. argillacea, has been described as emerging in In one patient the PCR was positive 5 months before culture. patients with CF [8,9]. ª 2014 The Authors. New Microbes and New Infections published by John Wiley & Sons Ltd on behalf of the European Society of Clinical Microbiology and Infectious Disease. Open access under CC BY license. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. NMNI Steinmann et al. PCR for Rasamsonia argillacea complex 73 Rasamsonia spp. are filamentous thermophilic fungi com- TABLE 1. Non-Rasamsonia strains (n = 39) tested for monly isolated from hot environments [10,11]. The species cross-reactivity in the Rasamsonia argillacea species complex R. argillacea was first described by Stolk et al. in 1969 under PCR the name Penicillium argillaceum [12]. Ten years later, Pitt Species Strain number renamed this species Geosmithia because of its morphological Fungi characteristics [13]. In 1999, this fungus was described for the Aspergillus cf. tamarii ATCC 64841 Aspergillus flavus CBS 113.49 first time in a French CF patient as P. emersonii based on Aspergillus fumigatus NCPF2140 A. fumigatus CBS 133.61 morphological characteristics [14]. In 2009, researchers A. fumigatus CBS 154.89 reported the first isolation of this organism from a dissemi- Aspergillus nidulans CBS 100.20 Aspergillus niger CBS 112.30 nated infection in a German Shepherd dog [15]. Recently, Aspergillus brasiliensis CBS 733.88 Aspergillus terreus CBS 469.81 Houbraken et al. showed that G. argillacea and other Geosmi- Aspergillus versicolor IMMI F81 Candida albicans ATCC 44374 thia species form a distinct clade within the Trichocomaceae Candida glabrata DSM 70614 Candida guilliermondii ATCC 90877 [16] and proposed the new genus Rasamsonia. In addition, Candida kefyr DSM1195 Candida krusei DSM 70075 phylogenetic analyses of the internal transcribed spacer, partial Candida parapsilosis ATCC 22019 b Candida tropicalis ATCC 750 -tubulin and calmodulin sequences revealed that R. argillacea Exophiala dermatitidis CBS 120550 is a species complex comprising four distinct species [16]. Fusarium solani IMMI 1650 Paecilomyces lilacinus IMMI 1900 Re-identification of nine published CF isolates from France Penicillium citrinum IMMI 1945 Penicillium notatum IMMI 2013 revealed three cases of R. argillacea, four colonizations with Pseudallescheria boydii FMR 84 Rhizomucor microsporus IMMI 1672 R. aegroticola, and two cases of R. piperina [8,16]. In contrast, Rhizomucor pusillus IMMI 1671 Scedosporium apiospermum IMMI F71 R. eburnea has also been found in sterile fluids of human origin Scedosporium prolificans IMMI F78 Bacteria but not in patients with CF [16]. Enterococcus faecalis ATCC 29212 Enterococcus faecium DSM 13590 In the present study, we validated a novel real-time PCR Staphylococcus aureus ATCC 43300 assay (PrimerDesignTM, Southampton, UK) for the detection of Staphylococcus epidermidis DSM 1789 Streptococcus pyogenes DSM 11728 the three species of the R. argillacea species complex typically Acinetobacter baumannii IMMI 150 Enterobacter cloacae IMMI 253 found in CF patients and compared the results of this assay Haemophilus influenzae DSM 9999 Klebsiella pneumoniae IMMI 251 with cultures of reference strains. In addition, we evaluated the Legionella pneumophila ATCC 33152 Proteus mirabilis DSM 4479 performance of this novel PCR assay by testing respiratory Serratia marcescens ATCC 13880 Mycobacterium tuberculosis ATCC 27294 samples from patients with CF. Mycobacterium avium DSM 44156 NCPF, national collection of pathogenic fungi; CBS, culture collection of the CBS-Fungal Biodiversity Centre, Utrecht, the Netherlands; ATCC, American Type Methods Culture Collection; IMMI, internal fungal collection of the Institute of Medical Microbiology, University Hospital Essen, Essen, Germany; FMR, Facultat de Medicina, Reus, Spain. Culture isolates In order to assess the specificity of the real-time PCR assay, 39 and two regions of the fungi, as was previously described for reference strains and clinical isolates from non-Rasamsonia Scedosporium spp. [17]. species from the fungal and bacterial culture collection of the Institute of Medical Microbiology (IMMI), University Hospital DNA extraction of cultured isolates Essen, Essen, Germany were analysed (Table 1). All fungal reference strains and clinical isolates were grown on Twenty-two reference strains belonging to the genus malt extract agar (Oxoid, Wesel, Germany) at 35°C for Rasamsonia were obtained from the collection of the Centra- 5 days. An agar block of approximately 1 cm2 in size was albureau voor Schimmelcultures (CBS)-Fungal Biodiversity transferred to a 1.5-mL reaction tube and homogenized with a Centre,

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    7 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us